Estrogen and the Ca2+-mobilizing agonist ATP evoke acute NO synthesis via distinct pathways in an individual human vascular endothelium-derived cell

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 6, 2008, Pages

  Sheng, Jian Zhong ^a   Arshad, Furqan ^a   Braun, Janice E ^a   Braun, Andrew P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Calcium; Endothelial function; Nitric oxide; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE; ANTIESTROGEN; APAMIN; CALCIUM ION; CHARYBDOTOXIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; 1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; 1,2-BIS(2-AMINOPHENOXY)ETHANE N,N,N',N'-TETRAACETIC ACID ACETOXYMETHYL ESTER; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHELATING AGENT; CHROMONE DERIVATIVE; DRUG DERIVATIVE; EGTAZIC ACID; ENZYME INHIBITOR; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; MORPHOLINE DERIVATIVE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR;

ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MICROFLUOROMETRY; PATCH CLAMP; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; CALCIUM SIGNALING; CELL LINE; CELL MEMBRANE POTENTIAL; CYTOPHOTOMETRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; TIME; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; APAMIN; CALCIUM SIGNALING; CELL LINE; CHARYBDOTOXIN; CHELATING AGENTS; CHROMONES; CYTOPHOTOMETRY; EGTAZIC ACID; ENDOTHELIAL CELLS; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; FLAVONOIDS; HUMANS; MEMBRANE POTENTIALS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN KINASE INHIBITORS; TIME FACTORS; UP-REGULATION;

EID: 47249099906     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00561.2007     Document Type: Article

References (52)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 489-494, 1995.
2. Boarder MR, Hourani SM. The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 19: 99-107, 1998.
3. Busse R, Fleming I, Hecker M. Signal transduction in endothelium-dependent vasodilatation. Eur Heart J 14, Suppl 1: 2-9, 1993.
4. Buxton ILO, Brunton LL. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 258: 10233-10239, 1983.
5. 2+ mobilization. Circ Res 81: 885-892, 1997.
6. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23: 665-686, 2002.
7. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 145: 113-125, 2004.
8. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401-406, 1999.
9. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
10. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737, 1983.
11. + channel activation in a human umbilical vein endothelial cell line. J Physiol (Lond) 524: 715-724, 2000.
12. Ca channel activity upon stimulation with a moderate histamine concentration in a human umbilical vein endothelial cell line. J Physiol (Lond) 540: 73-84, 2002.
13. Ca currents to hyperpolarize cultured porcine coronary artery endothelial cells. J Physiol (Lond) 519: 361-371, 1999.
14. Fulton D, Babbitt R, Zoellner S, Fontana J, Acevedo L, McCabe TJ, Iwakiri Y, Sessa WC. Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release. J Biol Chem 279: 30349-30357, 2004.
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh KB, Franke T, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
16. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299: 818-824, 2001.
17. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, Corson MA. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phoshorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 274: 30101-30108, 1999.
18. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96: 2788-2793, 1999.
19. 2+ elevation beneath the cell membrane. J Physiol (Lond) 506: 109-125, 1998.
20. Haynes MP, Sinha D, Strong Russel K, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677-682, 2000.
21. Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N, Murata Y. Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifne analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. J Biol Chem 276: 47642-47649, 2001.
22. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y. Estrogen induces the Akt-dependent activation of endothelial nitricoxide synthase in vascular endothelial cells. J Biol Chem 276: 3459-3467, 2001.
23. Isshiki M, Ying YS, Fujita T, Anderson RGW. A molecular sensor detects signal transduction from caveolae in living cells. J Biol Chem 277: 43389-43398, 2002.
24. Kim KH, Bender JR. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special? Sci STKE 288: pe28, 2005.
25. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 298: 249-258, 1994.
26. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, Nagano T. Fluorescent indicators for imaging nitric oxide production. Angew Chem Int Ed Engl 38: 3209-3212, 1999.
27. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol Lung Cell Mol Physiol 273: L119-L126, 1997.
28. 2+ influx. Biochem J 330: 695-699, 1998.
29. Lin S, Fagan KA, Li KX, Shaul PW, Cooper DMF, Rodman DM. Sustained endothelial nitric-oxide synthase activation requires capacitative calcium entry. J Biol Chem 275: 17979-17985, 2000.
30. Lissandron V, Zaccolo M. Compartmentalized cAMP/PKA signaling regulates cardiac excitation-contraction coupling. J Muscle Res Cell Motil 27: 399-403, 2006.
31. Lückhoff A, Busse R. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflügers Arch 416: 305-311, 1990.
32. Lückhoff A, Pohl U, Mülsch A, Busse R. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol 95: 189-196, 1988.
33. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain 'calcium-independent' eNOS activation by phosphorylation. J Biol Chem 275: 6123-6128, 2000.
34. Mendelsohn ME. Mechanisms of estrogen action in the cardiovascular system. J Steroid Biochem Mol Biol 74: 337-343, 2000.
35. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
36. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278: 9142-9149, 2003.
37. 1179. J Biol Chem 276: 30392-30398, 2001.
38. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
39. 2+: molecular determinants and functional consequences. Physiol Rev 86: 369-408, 2006.
40. + channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells. Am J Physiol Cell Physiol 293: C458-C467, 2007.
41. Sheng JZ, Wang D, Braun AP. DAF-FM (4-amino-5-methylamino- 2′,7′-difluorofluorescein) diacetate detects impairment of agonist-stimulated nitric oxide synthesis by elevated glucose in human vascular endothelial cells: reversal by vitamin C and L-sepiapterin. J Pharmacol Exp Ther 315: 931-940, 2005.
42. Sherman TS, Chambliss KL, Gibson LL, Pace MC, Mendelsohn ME, Pfister SL, Shaul PW. Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol 26: 610-616, 2002.
43. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541, 2000.
44. Simoncini T, Rabkin E, Liao JK. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 23: 198-203, 2003.
45. + channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. Br J Pharmacol 149: 560-572, 2006.
46. Stefano GB, Prevot V, Beauvillian JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, Bilfinger TV. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101: 1594 -1597, 2000.
47. Stirone C, Boroujerdi A, Duckles SP, Krause D. Estrogen receptor activation of phosphoinositide-3 kinase, Akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 67: 105-113, 2005.
48. Van Den Bemd GC, Kuiper GG, Pols HA, Van Leeuwen JP. Distinct effects on the conformation of estrogen receptor α and β by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. Biochem Biophys Res Commun 261: 1-5, 1999.
49. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
50. Wakeling AE, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873, 1991.
51. Zeng G, Nystrom FH, Ravichandran LV, Cong L, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101: 1539-1545, 2000.
52. Zhang Q, Church JE, Jagnandan D, Catravas JD, Sessa WC, Fulton D. Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells. Arterioscler Thromb Vasc Biol 26: 1015-1021, 2006.